Amyloid-β as a Blood Biomarker for Alzheimer’s Disease: A Review of Recent Literature-Reference-Cited by-同舟云学术

Amyloid-β as a Blood Biomarker for Alzheimer’s Disease: A Review of Recent Literature

Published:2020-02-04 Issue:3 Volume:73 Page:819-832
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Wang Xiaoni¹,Sun Yu¹,Li Taoran¹,Cai Yanning²,Han Ying¹³⁴

Affiliation:

1. Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China

2. Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of the Ministry of Education, Beijing, China

3. Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China

4. National Clinical Research Center for Geriatric Disorders, Beijing, China

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference93 articles.

1. Contributors NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease;Jack;Alzheimers Dement,2018

2. The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease;Braak;Brain,2015

3. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;McKhann;Alzheimers Dement,2011

4. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease;Palmqvist;Neurology,2015

5. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of beta-amyloid;Landau;Ann Neurol,2013

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of folic acid supplementation on cognitive function and inflammation in elderly patients with mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials;Archives of Gerontology and Geriatrics;2024-11

2. Complementary technologies for CSF biomarker analysis;New Insights on Cerebrospinal Fluid [Working Title];2024-09-03

3. Systematic review and meta-analysis of randomized controlled trials on the effects of exercise interventions on amyloid beta levels in humans;Experimental Brain Research;2024-03-29

4. Cerebrospinal and Blood Biomarkers in Alzheimer’s Disease: Did Mild Cognitive Impairment Definition Affect Their Clinical Usefulness?;International Journal of Molecular Sciences;2023-11-29

5. Physical activity and amyloid beta in middle-aged and older adults: A systematic review and meta-analysis;Journal of Sport and Health Science;2023-08